Literature DB >> 30848542

Osthole induced apoptosis in human normal liver cells by regulating cell proliferation and endoplasmic reticulum stress.

Zhelun Shen1, Jie Chen1, Hong Lu1.   

Abstract

Osthole (Ost) is often used in treatment for cancer, inflammation and rheumatism in clinic. However, Ost-induced liver injury has been reported. In this study, we aim to investigate the possible mechanism of Ost-induced hepatotoxicity in human normal liver cells (L02). When cells were exposed to Ost, the cell viability was decreased and apoptosis rate increased, the intracellular markers of oxidative stress were changed. Simultaneously, Ost altered apoptotic related proteins levels, including Bcl-2, Bax, Cleaved-Caspase-9/-8/-3, and Pro-Caspase-3/-8. In addition, Ost enhanced the levels of endoplasmic reticulum (ER) stress proteins (GRP78/Bip, CHOP, Caspase-4, IRE1α, PERK, JNK, P-JNK, and ATF4), decreased the cell proliferation and cycle-associated protein (Phospho-Histone H3, P-Cdc25C, Cdc25C, P-Cdc2, Cdc2, and Cyclin B1) level. The results show that Ost has toxic effects on L02 cells. Furthermore, it induces apoptosis by inhibiting cell proliferation, arresting cell cycle at the G2/M phase and activating ER stress.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ER stress; L02 cells; Osthole; apoptosis; cell proliferation

Mesh:

Substances:

Year:  2019        PMID: 30848542     DOI: 10.1002/tox.22743

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  2 in total

1.  Expression of glucose-regulated protein 78 as prognostic biomarkers for triple-negative breast cancer.

Authors:  Chenlian Yang; Zhiwei Zhang; Yutian Zou; Guanfeng Gao; Lingrui Liu; Haifan Xu; Feng Liu
Journal:  Histol Histopathol       Date:  2019-11-19       Impact factor: 2.303

Review 2.  Osthole: An up-to-date review of its anticancer potential and mechanisms of action.

Authors:  Shaojie Yang; Wanlin Dai; Jingnan Wang; Xiaolin Zhang; Yuting Zheng; Shiyuan Bi; Liwei Pang; Tengqi Ren; Ye Yang; Yang Sun; Zhuyuan Zheng; Shuodong Wu; Jing Kong
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.